Literature DB >> 12379930

Quantitative structure-pharmacokinetic/pharmacodynamic relationships of corticosteroids in man.

Donald E Mager1, William J Jusko.   

Abstract

The purpose of this study was to develop quantitative structure-activity/pharmacokinetic relationships (QSAR/QSPKR) for 11 selected corticosteroids in man. Multiple linear regression analysis with an automatic forward step-wise inclusion algorithm was used to construct QSAR/QSPKR models from molecular and submolecular descriptors that were generated using the SYBYL and KowWin computer programs. The final equations describing steroid relative receptor affinity, systemic clearance, volume of distribution, fraction unbound in plasma, and percent of oral absorption, all showed significant correlations (R(2) range 0.841 to 0.977). These relationships were crossvalidated using the leave-one-out method, and appeared to have good predictive performance (Q(2) range 0.715 to 0.912). In addition, a general method for integrating QSAR/QSPKR data to predict the time course of pharmacologic effects is presented. This approach, termed quantitative structure-pharmacodynamic relationships modeling, was successfully applied to predict the rapid cortisol suppressive effects of triamcinolone acetonide after a 2-mg intravenous bolus dose in healthy volunteers. Copyright 2002 Wiley-Liss, Inc. and the American Pharmaceutical Association J Pharm Sci 91:2441-2451, 2002

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12379930     DOI: 10.1002/jps.10231

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  12 in total

Review 1.  Inhaled corticosteroids in childhood asthma: long-term effects on growth and adrenocortical function.

Authors:  Alessandro Salvatoni; Elena Piantanida; Luana Nosetti; Luigi Nespoli
Journal:  Paediatr Drugs       Date:  2003       Impact factor: 3.022

2.  Quantitative structure-activity relationship and quantitative structure-pharmacokinetics relationship of 1,4-dihydropyridines and pyridines as multidrug resistance modulators.

Authors:  Xiao-Fei Zhou; Qingxiang Shao; Robert A Coburn; Marilyn E Morris
Journal:  Pharm Res       Date:  2005-09-20       Impact factor: 4.200

Review 3.  Modeling kinetics of subcellular disposition of chemicals.

Authors:  Stefan Balaz
Journal:  Chem Rev       Date:  2009-05       Impact factor: 60.622

Review 4.  Transitioning from Basic toward Systems Pharmacodynamic Models: Lessons from Corticosteroids.

Authors:  Vivaswath S Ayyar; William J Jusko
Journal:  Pharmacol Rev       Date:  2020-04       Impact factor: 25.468

5.  Calculated Log D Is Inversely Correlated With Select Camptothecin Clearance and Efficacy in Colon Cancer Xenografts.

Authors:  Charvi Nanavati; Donald E Mager
Journal:  J Pharm Sci       Date:  2016-04       Impact factor: 3.534

6.  Betamethasone pharmacokinetics after two prodrug formulations in sheep: implications for antenatal corticosteroid use.

Authors:  Mahesh N Samtani; Matthias Lohle; Angela Grant; Peter W Nathanielsz; William J Jusko
Journal:  Drug Metab Dispos       Date:  2005-04-28       Impact factor: 3.922

Review 7.  Pharmacokinetics and pharmacodynamics of systemically administered glucocorticoids.

Authors:  David Czock; Frieder Keller; Franz Maximilian Rasche; Ulla Häussler
Journal:  Clin Pharmacokinet       Date:  2005       Impact factor: 6.447

8.  Prediction of biliary excretion in rats and humans using molecular weight and quantitative structure-pharmacokinetic relationships.

Authors:  Xinning Yang; Yash A Gandhi; David B Duignan; Marilyn E Morris
Journal:  AAPS J       Date:  2009-07-11       Impact factor: 4.009

Review 9.  Structure-activity relationships and quantitative structure-activity relationships for breast cancer resistance protein (ABCG2).

Authors:  Yash A Gandhi; Marilyn E Morris
Journal:  AAPS J       Date:  2009-07-24       Impact factor: 4.009

10.  Pharmacokinetics of methylprednisolone after intravenous and intramuscular administration in rats.

Authors:  Anasuya Hazra; Nancy Pyszczynski; Debra C DuBois; Richard R Almon; William J Jusko
Journal:  Biopharm Drug Dispos       Date:  2007-09       Impact factor: 1.627

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.